These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28734041)

  • 1. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D; Wang JJ; Li JS; Xu QY
    Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C.
    Liao M; Peng L
    Cell Mol Biol Lett; 2020; 25():22. PubMed ID: 32206066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.
    Zhao L; Ni X; Zhao L; Zhang Y; Jin D; Yin W; Wang D; Zhang W
    Mol Pharm; 2018 Apr; 15(4):1682-1689. PubMed ID: 29528232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.
    Chi Y; Jin Q; Liu X; Xu L; He X; Shen Y; Zhou Q; Zhang J; Jin M
    Cancer Sci; 2017 Dec; 108(12):2366-2372. PubMed ID: 28921827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia.
    Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
    Life Sci; 2020 Aug; 255():117826. PubMed ID: 32450163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 11. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
    Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
    Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-98 Plays a Suppressive Role in Non-Small Cell Lung Cancer Through Inhibition of SALL4 Protein Expression.
    Liu W; Xiao P; Wu H; Wang L; Kong D; Yu F
    Oncol Res; 2017 Jul; 25(6):975-988. PubMed ID: 27938506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
    Wang L; Liu LF; Zhou L; Liao F; Wang J
    J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
    Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.
    Li Z; Li B; Niu L; Ge L
    Oncol Rep; 2017 Jan; 37(1):297-304. PubMed ID: 28004116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.
    Gao N; Wang FX; Wang G; Zhao QS
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1693-1699. PubMed ID: 29630114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
    Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
    Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.
    Zhou GH; Lu YY; Xie JL; Gao ZK; Wu XB; Yao WS; Gu WG
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30446524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.
    Sun CC; Li SJ; Li DJ
    Oncotarget; 2016 Jun; 7(24):35960-35978. PubMed ID: 27166267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.